The FDA announced on Aug. 20, 2025, that Northwind Pharmaceuticals LLC voluntarily recalled Sulfamethoxazole and Trimethoprim Tablets due to a foreign micro-organism found in auxiliary packaging coils. The agency classified the recall as Class II.
How to tell if you have it
- Brand: Northwind Pharmaceuticals
- Product: Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength
- NDCs: 51655-307-87 (6-count), 51655-307-53 (10-count), 51655-307-84 (14-count), 51655-307-20 (20-count)
- Lot codes: F118062503, F118062507, F118062504, F118062505, F118062509, F118062512, F118062506, F118062423, F118062501, F118062502, F118062508
- Distribution: Nationwide within the United States
The hazard
A specific lot of auxiliary polyester coil used in product packaging by manufacturer Amneal Pharmaceuticals LLC was detected with the presence of a micro-organism. The FDA stated that no micro-organism was detected on any tablets.
Context
GovInfoNow's records show Northwind Pharmaceuticals LLC has issued 3 other recalls since Nov. 10, 2015. Other recent recalls of similar products include Bionpharma Divalproex Tablets Recall (June 26, 2026), Amerisource Health Primidone Tablets Recall (May 1, 2026), and Harvard Drug Group Midodrine tablets recall (Feb. 17, 2026).